PURE Bioscience, Inc. Sale of Stock, Consideration Received on Transaction
PURE Bioscience, Inc. (PURE) reported Sale of Stock, Consideration Received on Transaction of $7.40 million for the 6-month period ending 2015-01-31, per its 10-Q filed 2016-03-09.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2016-03-09
- PURE Bioscience, Inc. sale of stock, consideration received on transaction for the quarter ending 2013-04-30 was $0.00.
- PURE Bioscience, Inc. sale of stock, consideration received on transaction for the quarter ending 2013-01-31 was $0.00.
- PURE Bioscience, Inc. sale of stock, consideration received on transaction for the quarter ending 2012-10-31 was $4.78M.
| Period end | Sale of Stock, Consideration Received on Transaction 0 month | Sale of Stock, Consideration Received on Transaction 3 month | Sale of Stock, Consideration Received on Transaction 6 month | Sale of Stock, Consideration Received on Transaction 9 month |
|---|---|---|---|---|
| 2015-01-31 | $7.40M 10-Q · filed 2016-03-09 | |||
| 2013-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-14 | $0.00 derived: sum of 2 quarters · filed 2013-06-14 | $4.78M 10-Q · filed 2013-06-14 | |
| 2013-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-25 | $4.78M 10-Q · filed 2013-02-25 | ||
| 2012-10-31 | $4.78M 10-Q · filed 2012-12-11 | |||
| 2012-09-17 | $4.23M 10-Q · filed 2013-12-12 |